Paul A. Meyers

Memorial Sloan Kettering Cancer Center

Full Professor(heuristic)

Sarcoma Diagnosis and Treatment · Pulmonary and Respiratory Medicine

h-index82

i10-index238

Publications389

Citations26,580

Grants

No NSF/NIH grants on record.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0014

PageRank within Pulmonary and Respiratory Medicine co-authorship network

Explore collaboration map

Admission Signals

New paper: Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High-Dose Alkylator–Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma (JCO oncology advances.)2026-04-01
New preprint: Supplementary Figure S1 from Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma2024-12-16

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0001-6146-6101

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 8 of 8

Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High-Dose Alkylator–Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
JCO oncology advances. · 2026-04-01
Trastuzumab Deruxtecan Is Active in Desmoplastic Small Round Cell Tumor
JCO oncology advances. · 2026-01-01 · 1 citations
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
JCO oncology advances. · 2025-03-01 · 2 citations
Supplementary Figure S1 from Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with SarcomaPreprint
2024-12-16
Data from Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with SarcomaPreprint
2024-12-16
Supplementary Figure S2 from Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with SarcomaPreprint
2024-12-16
Supplementary Table S1 from Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
2024-12-16
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Clinical Cancer Research · 2024-10-15 · 20 citations

Open author page on OpenAlex →